You are here

Amgen

Amgen juices up sales outlook amid high hopes for Celgene castoff Otezla

Fierce Pharma

Thu, 11/21/19 - 06:29 pm

Looking for a Biotech Stock That's an Ideal Buyout Candidate? This Is It.

Motley Fool

Wed, 11/20/19 - 10:02 am

If Biosimilars Are Struggling, Someone Forgot to Tell Coherus BioSciences

Motley Fool

Tue, 11/19/19 - 02:34 pm

Coherus Biosciences

Hit by copycat meds, Amgen trims 172 more jobs, this time in operations, R&D and sales

Fierce Pharma

Tue, 11/19/19 - 10:28 am

Top 10 pharma settlements since 2018

Fierce Pharma

Tue, 11/19/19 - 10:27 am

Reckitt Benckiser

Teva Pharmaceutical

AHA: Amgen's Repatha tied to greater risk reduction in high-risk heart attack patients

Fierce Pharma

Mon, 11/18/19 - 10:06 am

PCSK9 inhibitor

Ahead of FDA decision on BTK drug, Amgen-partnered BeiGene scores China OK for PD-1

Endpoints

Wed, 11/13/19 - 10:03 am

Amgen to cut 149 staff in retreat from neuroscience R&D

Fierce Biotech

Tue, 11/12/19 - 10:04 am

It took a 3-year struggle, but Novartis finally gets a green light on their copycat to Amgen's big blockbuster

Endpoints

Tue, 11/5/19 - 10:23 am

Biopharma Q3: Pfizer, Merck, Amgen, Incyte and J&J

BioSpace

Sat, 11/2/19 - 07:55 pm

Amgen pays $2.7bn to harness BeiGene’s China marketing muscle

Pharmaforum

Fri, 11/1/19 - 10:26 am

As Amgen zeroes in on cancer, neuroscience pipeline under the ax

Fierce Biotech

Wed, 10/30/19 - 10:20 am

Under copycat attack, Amgen punches back with its own biosimilars

Fierce Pharma

Tue, 10/29/19 - 10:48 pm

Bay Area Life Sciences Professionals Weigh In on Their Ideal Employers

BioSpace

Tue, 10/29/19 - 10:23 am

Gilead Sciences

The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings

Yahoo/Benzinga

Sun, 10/27/19 - 10:55 pm

Adamis Pharmaceuticals

Redhill Biopharma

Amag Pharmaceuticals

Agile Therapeutics

Agios Pharmaceuticals

Mirati Therapeutics

Sutro BioPharma

Bristol-Myers Squibb

Oyster Point Pharma

Amgen slashes price tag on cholesterol medicine Repatha by 60% for 2020

Yahoo/Reuters

Thu, 10/24/19 - 10:21 am

Mirati sets date for closely watched clinical KRAS readout

Fierce Biotech

Fri, 10/18/19 - 10:12 am

Mirati Therapeutics

UCB tries to win some respect in the crowded psoriasis market with a dual IL-17 approach — and it won't be easy

Endpoints

Thu, 10/17/19 - 10:24 am

Glenmark spin-out aims to challenge Amgen, others in cancer bispecific field

Biopharma Dive

Tue, 10/15/19 - 10:21 pm

Ichnos Sciences

bispecific antibodies

The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings

Yahoo/Benzinga

Mon, 10/14/19 - 09:43 am

Flexion Therapeutics

Clearside Biomedical

Assertio Therapeutics

Aldeyra Therapeutics

Lineage Therapeutics

Pages